Pharmacological inhibition of deaminase activity enhances increases in adenosine and prolongs anti-nociception actions of acupuncture. (a) Schematic diagram outlining the two major pathways involved in extracellular enzymatic degradation of AMP. The nucleoside analog deoxycoformycin inhibits both AMP deaminase (AMPD) and adenosine deaminase (ADA). (b) Histogram comparing the production of adenosine, IMP and inosine when tissue sections harvested close to the Zusanli point were incubated in 1 mM AMP and an inhibitor of adenosine uptake, nitrobenzylthioinosine (100 μM), for 45 min. Deoxycoformycin (500 μM) increased accumulation of adenosine while inhibiting the production of IMP and inosine (*P < 0.05, **P < 0.01, t test comparison between control and deoxycoformycin, n = 5). (c) Analysis of microdialysis samples collected close to the Zusanli point in mice treated with deoxycoformycin (50 mg per kg, intraperitoneal) or vehicle (saline). Deoxycoformycin increased accumulation of adenosine, while inhibiting the production of IMP in vivo during and after acupuncture (n = 6−8). (d,e) Deoxycoformycin (50 mg per kg, intraperitoneal) prolonged the anti-nociceptive effect of acupuncture in wild-type mice with inflammatory pain in response to mechanical (d) and thermal (e) stimulation (##P < 0.01, Tukey-Kramer test compared with before acupuncture, n = 6−10). (f,g) Deoxycoformycin prolonged the anti-nociceptive effect of acupuncture in wild-type mice with neuropathic pain induced by partial ligation of the ischias nerve to mechanical (f) and to thermal (g) stimulation (#P < 0.05, ##P < 0.01, Tukey-Kramer test compared with before acupuncture, n = 5). The sensitivity of the contralateral (control) leg to mechanical and thermal stimulation from these experiments is shown in Supplementary Figure 1. Error bars indicate s.e.m.